{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:53:55Z","timestamp":1789134835057,"version":"build-2803163510"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00451","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T04:39:56Z","timestamp":1539578396000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide"],"prefix":"10.3389","volume":"8","author":[{"given":"H. Ian","family":"Robins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuyTram N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Salamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin A.","family":"Deming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","article-title":"NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality","volume":"48","author":"Stupp","year":"2012","journal-title":"Eur J Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1109\/EMBC.2016.7592012","article-title":"Simplified realistic human head model for simulating Tumor Treating Fields (TTFields)","volume":"2016","author":"Wenger","year":"2016","journal-title":"Conf Proc IEEE Eng Med Biol Soc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/1097-0142(196111\/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H","article-title":"A biomathematical approach to clinical tumor growth","volume":"14","author":"Schwartz","year":"1961","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ijrobp.2015.11.042","article-title":"Improving tumor treating fields treatment efficacy in patients with glioblastoma using personalized array layouts","volume":"94","author":"Wenger","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy148.148","article-title":"Induction of autophagy following TTFields application serves as a survival mechanism mediated by AMPK activation","volume-title":"Proceedings of the 109th Annual Meeting of the American Association of Cancer Research 2018 Apr 14-18","author":"Shteingauz","year":"2018"},{"key":"B9","article-title":"Newly identified role of tumor treating fields in DNA damage repair and replication stress pathways","volume-title":"Proceedings of the 109th Annual Meeting of the American Association of Cancer Research (2018) Apr 14-18","author":"Karanam","year":"2018"},{"key":"B10","article-title":"Tumor treating fields (TTFields) decrease proliferation of patient-derived lung cancer brain metastasis cell in vitro","volume-title":"Proceedings of the 109th Annual Meeting of the American Association of Cancer Research 2018 Apr 14-18","author":"Michelhaugh","year":"2018"},{"key":"B11","article-title":"Tumor treating fields exert cellular and immunologic effects","volume-title":"Proceedings of the 109th Annual Meeting of the American Association of Cancer Research 2018 Apr 14-18","author":"Wong","year":"2018"},{"key":"B12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","article-title":"Implications of genetic and epigenetic alterations of CDKN2A (p16 (INK4a)) in cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"Ebio Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signaling pathway in human cancer","volume":"13","author":"Populo","year":"2012","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T17:04:14Z","timestamp":1572109454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":13,"alternative-id":["10.3389\/fonc.2018.00451"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00451","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"article-number":"451"}}